Recombinant IL4R (Dupilumab Biosimilar) antibody
Quick Overview for Recombinant IL4R (Dupilumab Biosimilar) antibody (ABIN7488008)
Target
Antibody Type
Reactivity
Host
Clonality
Application
Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Dupilumab Biosimilar - Anti-IL4R, CD124 mAb
-
Characteristics
- Antibody Type: IgG4-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG4 kappa
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IL4R (Dupilumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
CD124,REGN668,SAR231893
Dupilumab is a human monoclonal antibody of isotype IgG4 that targets the interleukin-4 (IL-4) receptor, inhibiting the receptor signaling pathways. Dupilumab inhibits the signaling pathway of interleukins, that induce inflammatory and immunological reactions in several atopic or allergic conditions, such as eczema, allergic reaction, and rhinosinusitis. -
CAS-No
- 1190264-60-8
Target
-